GENE ONLINE|News &
Opinion
Blog

Alzheimer's drug development
Neurodegenerative Diseases clinical data
Eight Phase 3 Trials, 29 Phase 2 Readouts, and a Diversifying Pipeline: Eyes on Alzheimer’s in 2026
2026-06-02
LATEST
Forward Issues Non-Binding Letter of Intent to Acquire Brera Holdings PLC
2026-06-09
Snap-on Incorporated Acquires Diagnostic Provider Diesel Laptops
2026-06-09
HyOrc Corporation Retains Stonegate Capital Partners to Assist With Nasdaq Uplisting Strategy
2026-06-09
Prospect Media Group Launches Shopography Platform to Track Retail Store Visitation Data
2026-06-09
Ramaco Resources Leadership to Participate in StoneX Natural Resources Summit
2026-06-09
Allison Transmission to Supply Automatic Transmissions for French Land Forces Tactical Trucks
2026-06-09
Representative Jake Auchincloss Seeks Industry Feedback on Clinical Trial Reform Legislation
2026-06-09
READ MORE
EVENT
20260622
BIO International Convention (Global Biotech Showcase)
Boston, Massachusetts
20260625
Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health)
Taipei, Taiwan
20260625
ASCO Breakthrough 2026 (Next-Gen Oncology Innovation)
Singapore
20260708
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
20260715
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
20260807
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
SEE MORE
Scroll to Top